These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33593238)

  • 1. Cannabis Consumption, Purchasing and Sources among Young Canadians: The Cannabis Purchase and Consumption Tool (CPCT).
    Sikorski C; Leos-Toro C; Hammond D
    Subst Use Misuse; 2021; 56(4):449-457. PubMed ID: 33593238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How have cannabis use and related indicators changed since legalization of cannabis for non-medical purposes? Results of the Canadian Cannabis Survey 2018-2022.
    Goodman S; Dann MJ; Fataar F; Abramovici H
    Int J Drug Policy; 2024 May; 127():104385. PubMed ID: 38520961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis flower prices and transitions to legal sources after legalization in Canada, 2019-2020.
    Wadsworth E; Driezen P; Pacula RL; Hammond D
    Drug Alcohol Depend; 2022 Feb; 231():109262. PubMed ID: 34998249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retail availability and legal purchases of dried flower in Canada post-legalization.
    Wadsworth E; Driezen P; Hammond D
    Drug Alcohol Depend; 2021 Aug; 225():108794. PubMed ID: 34098382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
    Goodman S; Wadsworth E; Leos-Toro C; Hammond D;
    Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On offer to Ontario consumers three years after legalization: A profile of cannabis products, cannabinoid content, plant type, and prices.
    Tassone F; Di Ciano P; Liu Y; Rueda S
    Front Psychiatry; 2023; 14():1111330. PubMed ID: 36873222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis health knowledge and risk perceptions among Canadian youth and young adults.
    Leos-Toro C; Fong GT; Meyer SB; Hammond D
    Harm Reduct J; 2020 Aug; 17(1):54. PubMed ID: 32746859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of potency, warning messages, and price on preferences for Cannabis flower products.
    Shi Y; Cao Y; Shang C; Pacula RL
    Int J Drug Policy; 2019 Dec; 74():1-10. PubMed ID: 31382201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drivers of purchase decisions for cannabis products among consumers in a legalized market: a qualitative study.
    Donnan J; Shogan O; Bishop L; Najafizada M
    BMC Public Health; 2022 Feb; 22(1):368. PubMed ID: 35189856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Young adults' familiarity with different cannabis product terms: the need for standardized cannabis surveys.
    Berberian S; Broussard ML; Tully C; Methuku V; Pardini DA; Meier MH
    J Cannabis Res; 2022 Apr; 4(1):14. PubMed ID: 35365236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.
    Fischer B; Lee A; Robinson T; Hall W
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):77. PubMed ID: 34620191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retail price and availability of illicit cannabis in Canada.
    Mahamad S; Hammond D
    Addict Behav; 2019 Mar; 90():402-408. PubMed ID: 30530299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triangulating web & general population surveys: Do results match legal cannabis market sales?
    Caulkins JP; Davenport S; Doanvo A; Furlong K; Siddique A; Turner M; Kilmer B
    Int J Drug Policy; 2019 Nov; 73():293-300. PubMed ID: 31272752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study.
    Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W
    Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking back from 2020, how cannabis use and related behaviours changed in Canada.
    Rotermann M
    Health Rep; 2021 Apr; 32(4):3-14. PubMed ID: 33881274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental Health and Medical Cannabis Use among Youth and Young Adults in Canada.
    Wadsworth E; Leos-Toro C; Hammond D
    Subst Use Misuse; 2020; 55(4):582-589. PubMed ID: 31747851
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevalence of cannabis use and the frequency, types, and sources of cannabis products used in northern remote territories of the Canadian legal cannabis market.
    Hobin E; Schwartz N; Poon T; Hammond D
    Can J Public Health; 2024 Aug; 115(4):628-638. PubMed ID: 38760617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity.
    Callaghan RC; Sanches M; Benny C; Stockwell T; Sherk A; Kish SJ
    Drug Alcohol Depend; 2019 Dec; 205():107587. PubMed ID: 31600617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationally representative surveys on cannabis use lack product details relevant to public health.
    Stith S; Pearson J; Brockelman F; Keeling K; Hall B; Friedman AS
    Drug Alcohol Depend Rep; 2023 Mar; 6():100134. PubMed ID: 36994372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring consumer preferences for cannabis edible products to support public health policy: A discrete choice experiment.
    Donnan J; Johnston K; Coombs M; Najafizada M; Bishop L
    PLoS One; 2024; 19(5):e0292336. PubMed ID: 38753807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.